# Intermittent Fasting and CLL/SLL

> **NCT04626843** · PHASE1 · COMPLETED · sponsor: **Eleah Stringer** · enrollment: 15 (actual)

## Conditions studied

- Neoplasms
- Leukemia, Lymphocytic, Chronic
- Lymphoma, Small Lymphocytic
- Intermittent Fasting
- Diet Habit
- Inflammation

## Interventions

- **OTHER:** Intermittent fast

## Key facts

- **NCT ID:** NCT04626843
- **Lead sponsor:** Eleah Stringer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04626843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04626843, "Intermittent Fasting and CLL/SLL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04626843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*